It has been shown that GM-CSF-secreting tumor cell immunotherapy with VEFG-blocking agents prolonged survival of cancer bearing mice [155, 156], while IL-2 and GM-CSF can have a suppressive effect on Tregs [92, 93]. This evidence concerns the gene CSF2 and cancer.